Published in West J Med on April 01, 1995
Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics (2010) 1.33
Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr (2012) 1.08
Kawasaki's disease: An unusual presentation. J Cardiovasc Dis Res (2012) 0.86
Changes of clinical characteristics and outcomes in patients with Kawasaki disease over the past 7 years in a single center study. Korean J Pediatr (2013) 0.81
Procalcitonin levels in patients with complete and incomplete Kawasaki disease. Dis Markers (2013) 0.80
Recurrent Kawasaki disease: USA and Japan. Pediatr Int (2015) 0.79
Very high serum ferritin levels in three newborns with Kawasaki-like illness. Paediatr Child Health (2012) 0.75
Recognizing Kawasaki disease. Paediatr Child Health (2001) 0.75
Hemophagocytosis in the Acute Phase of Fatal Kawasaki Disease in a 4 Month-Old Girl. Balkan Med J (2016) 0.75
Clinical Characteristics of Kawasaki Disease in Infants Younger than Six Months: A Single-Center Study. Korean Circ J (2016) 0.75
Coronary artery involvement in Kawasaki disease--diagnosis and treatment. West J Med (1995) 0.75
Myocardial Layers Specific Strain Analysis for the Acute Phase of Infant Kawasaki Disease. Pediatr Cardiol (2016) 0.75
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi (1967) 9.06
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
High-dose intravenous gammaglobulin for Kawasaki disease. Lancet (1984) 3.10
Mucocutaneous lymph node syndrome in the United States. Am J Dis Child (1976) 2.52
Kawasaki disease. Relationship with infantile periarteritis nodosa. Arch Pathol Lab Med (1976) 2.10
Kawasaki syndrome. Rev Infect Dis (1988) 1.55
POLYARTERITIS NODOSA IN INFANCY. J Pediatr (1963) 1.54
Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan. Pediatrics (1977) 1.48
Incomplete Kawasaki disease with coronary artery involvement. J Pediatr (1987) 1.46
Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr (1986) 1.34
Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr (1986) 1.29
Kawasaki syndrome: review of new epidemiologic and laboratory developments. Pediatr Infect Dis J (1987) 1.26
Infantile periarteritis nodosa with coronary and brachial aneurysms: a case diagnosed during life. J Pediatr (1971) 1.07
Mucocutaneous lymph node syndrome (MLNS): a disease widespread in Japan which demands our attention. Pediatrics (1974) 1.02
Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J (1990) 0.95
Coronary aneurysms in a patient with atypical Kawasaki syndrome and a streptococcal infection. Pediatr Cardiol (1985) 0.92
Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease. JAMA (1985) 0.92
Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms. Am J Cardiol (1986) 0.91
Necrotizing arteritis of the coronary vessels in infancy; case report and review of the literature. Pediatrics (1959) 0.90
Lethal vasculitis of coronary arteries in a neonate and two infants: possible neonatal variant of the MLNS/IPN complex? Helv Paediatr Acta (1981) 0.90
Atypical Kawasaki disease. Prog Clin Biol Res (1987) 0.86
Kawasaki syndrome: issues in etiology and treatment. Adv Pediatr Infect Dis (1989) 0.84
Atypical presentation of Kawasaki disease with early development of giant coronary artery aneurysms. J Pediatr (1989) 0.83
Atypical Kawasaki disease with aortic aneurysm. Pediatrics (1981) 0.83
Periarteritis nodosa in infancy. Am J Dis Child (1968) 0.83
Spectrum of cardiovascular lesions in mucocutaneous lymph node syndrome: analysis of eight cases. Am J Cardiol (1980) 0.82
Incomplete Kawasaki disease with facial nerve paralysis and coronary artery involvement. Pediatr Infect Dis J (1988) 0.82
An atypical presentation of Kawasaki syndrome in an infant. Pediatr Dermatol (1988) 0.80
Diagnostic uncertainty in atypical Kawasaki disease, and a new finding: exudative conjunctivitis. Pediatr Infect Dis (1985) 0.79
Kawasaki disease with atypical presentation. Pediatr Infect Dis J (1988) 0.78
Fatal case of atypical Kawasaki syndrome. Pediatr Infect Dis J (1987) 0.78
Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol (2001) 4.63
Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis (1997) 2.65
In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species. Antimicrob Agents Chemother (1997) 2.51
Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol (2000) 2.50
An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep (1999) 2.04
Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr Infect Dis J (1996) 1.48
Antibiotic dosages in the treatment of group A streptococcal infections. Clin Pediatr (Phila) (1992) 1.37
Mycobacterium parascrofulaceum sp. nov., novel slowly growing, scotochromogenic clinical isolates related to Mycobacterium simiae. Int J Syst Evol Microbiol (2004) 1.32
The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication. Pediatr Infect Dis J (2000) 1.27
Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT). Clin Infect Dis (1999) 1.26
Abortion and perinatal sepsis associated with campylobacter infection. Rev Infect Dis (1986) 1.22
Historic low Haemophilus influenzae type B case tally--Canada 2000. Can Commun Dis Rep (2001) 1.17
Sequelae of acute bacterial meningitis in children treated for seven days. Pediatrics (1986) 1.17
Helicobacter pylori in the Canadian arctic: seroprevalence and detection in community water samples. Am J Gastroenterol (1999) 1.16
Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian population. Dig Dis Sci (1999) 1.10
Mycobacterium saskatchewanense sp. nov., a novel slowly growing scotochromogenic species from human clinical isolates related to Mycobacterium interjectum and Accuprobe-positive for Mycobacterium avium complex. Int J Syst Evol Microbiol (2004) 1.05
Arthritis associated with Haemophilus influenzae meningitis: septic or reactive? J Pediatr (1986) 1.04
In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species. Antimicrob Agents Chemother (1997) 1.04
M. tuberculosis molecular variation in CNS infection: evidence for strain-dependent neurovirulence. Neurology (1998) 0.98
Disseminated bacille Calmette-Guérin infection: three recent Canadian cases. IMPACT. Immunization Monitoring Program, Active. Can Commun Dis Rep (1998) 0.97
Production and characterization of chimeric transferrins for the determination of the binding domains for bacterial transferrin receptors. J Biol Chem (1996) 0.94
Varicella zoster virus infections in Canadian children in the prevaccine era: A hospital-based study. Can J Infect Dis (1997) 0.93
Brain abscesses in infants and children. Pediatr Infect Dis (1985) 0.92
Practice guidelines for ordering stool ova and parasite testing in a pediatric population. The Alberta Children's Hospital. Am J Clin Pathol (1995) 0.88
Recurrent urethritis associated with Ureaplasma urealyticum in a prepubertal boy. Pediatr Infect Dis J (1987) 0.88
Regional dissemination and control of epidemic methicillin-resistant Staphylococcus aureus. Manitoba Chapter of CHICA-Canada. Infect Control Hosp Epidemiol (1999) 0.87
Mycobacterium branderi from both a hand infection and a case of pulmonary disease. J Clin Microbiol (2000) 0.86
Epidemiology and outcome of osteomyelitis in the era of sequential intravenous-oral therapy. Pediatr Infect Dis J (1998) 0.85
Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis. Can J Infect Dis (2001) 0.84
Tunneled central venous catheter sepsis: risk factors in a pediatric hospital. JPEN J Parenter Enteral Nutr (1991) 0.84
Strain-related virulence of the dominant Mycobacterium tuberculosis strain in the Canadian province of Manitoba. Tuberculosis (Edinb) (2004) 0.83
Evaluation of the Strep A OIA assay versus culture methods: ability to detect different quantities of group A Streptococcus. Diagn Microbiol Infect Dis (1999) 0.82
Low prevalence of VRE gastrointestinal colonization of hospitalized patients in Manitoba tertiary care and community hospitals. Can J Infect Dis (2000) 0.82
Severe Kawasaki disease in infants: two fatal cases. Can J Cardiol (2000) 0.82
Low prevalence of gastrointestinal colonization with antimicrobial-resistant bacteria in high risk units in a Canadian tertiary care centre. Can J Infect Dis (1996) 0.81
Predictors and outcome of admission for invasive Streptococcus pneumoniae infections at a Canadian children's hospital. Clin Infect Dis (1998) 0.81
Rifampin alone or with trimethoprim for contacts of children with Haemophilus influenzae type b infections. CMAJ (1986) 0.81
Population-based surveillance of Hib invasive infections in children in British Columbia Alberta and Ontario - 1995 to 1997. Can J Infect Dis (2000) 0.81
Chronic recurrent multifocal osteomyelitis: a rare disorder presenting as multifocal bone lesions. Med Pediatr Oncol (2001) 0.80
Reduced susceptibility to penicillin among pneumococci causing invasive infection in children - Canada, 1991 to 1998. Can J Infect Dis (2001) 0.80
Treatment of Mycobacterium marinum facial abscess using clarithromycin. Pediatr Infect Dis J (1995) 0.80
Identification of a predominant isolate of Mycobacterium tuberculosis using molecular and clinical epidemiology tools and in vitro cytokine responses. BMC Infect Dis (2003) 0.80
Enterococcal bacteremia in a tertiary care centre in Winnipeg. Can J Infect Dis (1999) 0.79
Practice guidelines for ordering stool cultures in a pediatric population. Alberta Children's Hospital, Calgary, Alberta, Canada. Am J Clin Pathol (1995) 0.78
The use of intravenous gammaglobulin in the treatment of typical hemolytic uremic syndrome. Pediatr Nephrol (1991) 0.78
Differential yield of pathogens from stool testing of nosocomial versus community-acquired paediatric diarrhea. Can J Infect Dis (1999) 0.77
Fatal neonatal pneumonia caused by adenovirus type 35. Report of one case and review of the literature. Arch Pathol Lab Med (1992) 0.76
Use of ganciclovir in the treatment of acquired cytomegalovirus disease in a preterm infant. Can J Infect Dis (1990) 0.75
Meningitis due to ampicillin-and chloramphenicol-resistant Haemophilus influenzae type b in Canada. Case report and review. Can J Infect Dis (1990) 0.75
In vitro interactions between rifampin and ampicillin or chloramphenicol against Haemophilus influenzae. Antimicrob Agents Chemother (1984) 0.75
Dactylitis in a child with sickle cell trait. Can Med Assoc J (1985) 0.75
Ciprofloxacin or imipenem use correlates with resistance in Pseudomonas aeruginosa. Can J Infect Dis (1998) 0.75
Transient in vivo selection of a constitutively cephalosporin resistant Enterobacter cloacae causing ventriculitis. Can J Infect Dis (1995) 0.75
Haemophilus influenzae type b resistant to ampicillin and chloramphenicol. Pediatr Infect Dis J (1990) 0.75
The Immunization Monitoring Program-active (IMPACT) prospective surveillance of varicella zoster infections among hospitalized Canadian Children: 1991-1996. Can Commun Dis Rep (2000) 0.75
Hydrocele in Kawasaki disease: importance in early recognition of atypical disease. Am J Dis Child (1991) 0.75
A case of western equine encephalitis--Alberta. Can Dis Wkly Rep (1989) 0.75
Congenital malaria: a case report of a preventable disease. Pediatr Infect Dis J (1990) 0.75
Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease. J R Soc Health (1988) 0.75
Once versus thrice daily tobramycin alone and in combination with ceftazidime, ciprofloxacin and imipenem in an in vitro pharmacodynamic model. Chemotherapy (1998) 0.75
Sequelae of acute bacterial meningitis in children. Antibiot Chemother (1971) (1992) 0.75
Hypotonic-hyporesponsive episodes in children hospitalized at 10 Canadian Pediatric Tertiary-Care Centres, 1991-1994. Can Commun Dis Rep (1997) 0.75